Tom Gallen
Managing Editor, Europe
Latest From Tom Gallen
Stada Grows Twice As Fast As CHC Market In 2023
Stada's local brand focus helped it deliver Consumer Healthcare sales growth of 16% in 2023 ensuring the German firm significantly outpaced the overall market growth rate of 7%.
Karo Expands Intimate Health Offering With Bayer's Proctosedyl
Sweden's Karo has struck its second deal in six months bringing in the Proctosedyl hemorrhoid brand from Bayer.
Bayer Looks To Asia Pacific To Beat Consumer Health Market Growth
Unleashing its potential in China, India and Southeast Asia is central to Bayer's ambition to grow faster than the consumer health market over the next few years.
Bayer To Hold On To Consumer Health While It Deals With More Pressing Issues
With Bayer "badly broken in four places," now is not the right time to consider offloading its Consumer Health business, according to group CEO Bill Anderson. Bayer must focus its full attention for the next few years on addressing challenges which include mounting debt and costly litigation before a change to the company's structure can be considered.
Bayer Consumer Health Names New President In Surprise Move
Heiko Schipper is departing for Unilever with Bayer Consumer Health promoting Julio Triana to take over just days before a capital markets day which will set the future direction of the business.
Haleon Surprises Analysts With Stand-Out Cold & Flu Showing In Q4
In describing Haleon’s Q4 showing as a “strong finish to the year,” Bernstein’s Bruno Monteyne pointed to “remarkable strength in respiratory health,” with the category resoundingly beating analysts’ consensus estimates of a 2.5% decline.